Key result
Potentially malignant pre-TAVR CT findings do not influence therapeutic decisions or 2-year survival.
Why the study?
Does the presence of potentially malignant incidental findings on pre-procedural CT influence therapeutic decisions or 2-year survival in patients screened for TAVR?
Observational (n=414)
No
Does the presence of potentially malignant incidental findings on pre-procedural CT influence therapeutic decisions or 2-year survival in patients screened for TAVR?
Odds Ratio: 1.14
p-value: p=0.835
Potentially malignant incidental findings on pre-TAVR CT are common but do not significantly impact the heart team's decision to intervene or 2-year survival.
No takes yet. Share an insight, caveat, or question.
Supports TAVR decisions despite incidental findings; leaves open need for prospective studies on management impact.
Stachon et al. (2015) conducted an observational in inoperable aortic valve stenosis (n=414). Potentially malignant incidental findings (pmIFs) vs. No pmIF was evaluated on Therapeutic decisions (decision to intervene by TAVR or SAVR) (OR 1.14, p=0.835). Potentially malignant incidental findings on pre-procedural CT did not significantly influence therapeutic decisions (OR 1.14; P=0.835) or 2-year survival (~75%) in patients screened for TAVR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: